Delivery Order SPE2DB22D3501-SPE2DB25FUE11
Award Date
1/15/25
Potential Completion Date
2/6/25
Potential Value
$5.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $10,238.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INQOVI 35 MG-100 MG TABLET, a pharmaceutical product, and has a completion date of March 6, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. In addition to this specific contract,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $5,119.36 and is a Firm Fixed Price Delivery Order that runs through February 26, 2025. The contract is not designated as a set-aside. The contract covers the delivery of the pharmaceutical product INQOVI 35 MG-100 MG TABLET, which is likely used in federal healthcare programs, potentially...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,740.78, is for the delivery of INQOVI 35 MG-100 MG tablets. It is a Firm Fixed Price delivery order with a completion date of November 7, 2023. The contract is not designated as a set-aside and represents open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order awarded to AmerisourceBergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) for the supply of pharmaceutical products, specifically the drug INQOVI 35 MG-100 MG TABLET. The contract has a firm-fixed price of $14,491.41 and a completion date of September 26, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of INQOVI 35 MG-100 MG tablets. The contract has a ceiling value of $4,830.47 and a completion date of July 15, 2024. It is a Firm Fixed Price Delivery Order contract, without any set-aside designation. Amerisourcebergen, through its Corporate Office Division, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,830.47 firm-fixed-price delivery order is for the supply of the medication INQOVI 35 MG-100 MG TABLET, with a performance period through November 6, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,997.42, is for the delivery of INQOVI 35 MG-100 MG TABLET to support military healthcare programs. The contract is a firm fixed-price delivery order with an ultimate completion date of December 12, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,997.42, is for the delivery of the drug Inqovi 35 mg-100 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of January 21, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order from the Defense Logistics Agency (DLA) valued at $5,119.36. The contract is for the supply of INQOVI 35 MG-100 MG TABLET, a pharmaceutical product, to support military healthcare programs. The contract has a period of performance through March 13, 2025 and is a Firm Fixed Price contract type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,740.79 firm fixed-price delivery order is for the supply of INQOVI 35 MG-100 MG tablets, with a period of performance ending on March 27, 2023. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...